Cargando…
Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target
Lysine-specific histone demethylase 3 (KDM3) subfamily proteins are H3K9me2/me1 histone demethylases that promote gene expression. The KDM3 subfamily primarily consists of four proteins (KDM3A−D). All four proteins contain the catalytic Jumonji C domain (JmjC) at their C-termini, but whether KDM3C h...
Autores principales: | Yoo, Jung, Jeon, Yu Hyun, Cho, Ha Young, Lee, Sang Wu, Kim, Go Woon, Lee, Dong Hoon, Kwon, So Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280979/ https://www.ncbi.nlm.nih.gov/pubmed/32354028 http://dx.doi.org/10.3390/cancers12051098 |
Ejemplares similares
-
Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
por: Yoo, Jung, et al.
Publicado: (2022) -
Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc
por: Lee, Dong Hoon, et al.
Publicado: (2021) -
Benzo[b]tellurophenes as a Potential Histone H3 Lysine 9 Demethylase (KDM4) Inhibitor
por: Kim, Yoon-Jung, et al.
Publicado: (2019) -
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
por: Jose, Anmi, et al.
Publicado: (2020) -
The Histone Demethylase KDM5 Is Essential for Larval Growth in Drosophila
por: Drelon, Coralie, et al.
Publicado: (2018)